Osteopore

Osteopore Current Liabilities

The Current Liabilities of Osteopore (OSX.AX) as of Oct 29, 2026 is 3.05 M AUD. In the previous year, Current Liabilities was 3.00 M AUD — a change of 1.58% (higher).

Current Liabilities

3.05 MAUD

YoY

1.58%

Last updated:

Current Liabilities of Osteopore is 2025 3.05 M AUD. Current Liabilities of Osteopore was 2024 3.00 M AUD. It decreases by 1.58% higher compared to the previous year.

The Osteopore Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
1.17 M AUD
Jan 1, 2019
1.75 M AUD
Jan 1, 2020
1.74 M AUD
Jan 1, 2021
829,599.00 AUD
Jan 1, 2022
2.04 M AUD
Jan 1, 2023
3.26 M AUD
Jan 1, 2024
3.00 M AUD
Jan 1, 2025
3.05 M AUD
The Osteopore Current Liabilities history
YEARCurrent LiabilitiesYoY
3.05 MAUD+1.58%
3.00 MAUD-7.84%
3.26 MAUD+59.43%
2.04 MAUD+146.23%
829,599.00AUD-52.21%
1.74 MAUD-0.92%
1.75 MAUD+49.90%
1.17 MAUD-56.63%
2.70 MAUD+21.67%
2.22 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Osteopore Stock analysis

What does Osteopore do? Osteopore Ltd. develops and markets bioresorbable polymer implants for neurosurgical, orthopaedic, and maxillofacial surgeries. The company commercializes bespoke products engineered to facilitate bone healing, utilizing patented technology that fabricates micro-structured scaffolds through 3D printing and bioresorbable materials. Key products include Osteoplug in plug and strip configurations for craniotomy gap filling, Osteomesh, and Osteoplug-C for craniofacial applications. These solutions support bone tissue integration from the skull to the bone flap, targeting procedures such as cranioplasty, craniosynostosis, and guided bone regeneration. The company serves medical professionals and healthcare facilities requiring advanced bone regeneration solutions. Its products are designed for specific surgical applications including craniotomy, orbital floor reconstruction, socket preservation, and minimally invasive skull base surgery. Osteopore Ltd. focuses on delivering patient-specific implants (PSI) for cranial and mandibular procedures, alongside solutions for burr hole restoration with shunt drainage systems. These offerings cater to specialized surgical segments demanding precision and biocompatibility. Osteopore Ltd.'s revenue streams derive from the sale of its proprietary implant systems to hospitals and surgical centers. The company’s technology enables the production of custom implants that address complex bone healing needs, particularly in neurosurgery, orthopaedics, and maxillofacial procedures. By providing tailored solutions for cranioplasty, craniosynostosis, and guided bone regeneration, the company meets the demands of healthcare providers seeking effective bone regeneration technologies. Osteopore is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Osteopore stock

Current Liabilities of Osteopore is 3.05 M AUD in 2025.

Current Liabilities of Osteopore changed from 3.00 M AUD to 3.05 M AUD, representing a 1.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Osteopore since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Osteopore historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Osteopore

All Key Metrics — Osteopore